Comparative Pharmacology
Head-to-head clinical analysis: CODRIX versus COLD CAPSULE IV.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CODRIX versus COLD CAPSULE IV.
CODRIX vs COLD CAPSULE IV
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Codrix is a combination of codeine (a mu-opioid receptor agonist) and paracetamol (cyclooxygenase inhibitor, primarily in the CNS). Codeine is metabolized to morphine via CYP2D6, which mediates opioid effects. Paracetamol inhibits prostaglandin synthesis, providing analgesic and antipyretic effects.
Combination of antihistamine (chlorpheniramine) blocking H1 receptors, nasal decongestant (phenylephrine) causing vasoconstriction, and analgesic/antipyretic (acetaminophen) inhibiting COX enzymes in CNS.
2 mg orally once daily.
1-2 capsules orally every 4-6 hours as needed for symptoms; maximum 12 capsules per day.
None Documented
None Documented
Terminal half-life 12-15 hours; steady-state reached in 2-3 days.
Acetaminophen: 2-3 hours (prolonged in hepatic impairment). Pseudoephedrine: 5-8 hours (alkaline urine increases half-life). Dextromethorphan: 3-5 hours (CYP2D6 poor metabolizers: up to 20 hours).
Primarily renal (60% unchanged) and biliary/fecal (30%); 10% metabolized.
Renal elimination of acetaminophen metabolites (primarily glucuronide and sulfate conjugates) accounts for ~85-90% of the dose; unchanged drug <5%. Pseudoephedrine and dextromethorphan are primarily excreted renally (70-90% and 50-80% respectively, with some biliary/fecal).
Category C
Category C
Cold & Cough Combination
Cold & Cough Combination